Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Observational, Multicenter Study on the Safety and Efficacy of Apixaban for the Prevention of Thromboembolism in Adults With Congenital Heart Disease and Atrial Arrhythmias: the PROTECT-AR Study

NCT03854149 is registered in ClinicalTrials.gov with AHEPA University Hospital as lead sponsor.

NCT NCT03854149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03854149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Observational, Multicenter Study on the Safety and Efficacy of Apixaban for the Prevention of Thromboembolism in Adults With Congenital Heart Disease and Atrial Arrhythmias: the PROTECT-AR Study
Lead sponsor
AHEPA University Hospital
Phase
Observational
Overall status
Completed
Start date
July 1, 2019
Completion date
May 30, 2023
Enrollment
218 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulants causing adverse effects in therapeutic use, atrial arrhythmia, congenital heart disease, thromboembolism